Further work is also necessary to elucidate the long term course of IPA in CD11b−/− mice with regard to the interplay of PMN with DC, the efficacy of adaptive immune responses, and the potential pulmonary overexpression of CCL5. The gene discussed is CCL5; the disease is Ito hypomelanosis.